🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

One day after world blood cancer day: stamina and world wide networks to advance are field are rewarded: Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort sciencedirect.com/science/articl…

Finally out kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2… The genesis of The EBMT #CART Cells registry Jurgen Kuball Mohamad Mohty Anna Sureda Annalisa Ruggeri

9000 it was and let’s go for the 10.000: Celebrating the registration of 9.000 patients treated with CAR T cell... sciencedirect.com/science/articl… Christian Chabannon EBMT_Cellular_Therapy Annalisa Ruggeri Anna Sureda The EBMT GoCART_Coalition

Last days of a survey of ⁦GoCART_Coalition⁩ ⁦T2EVOLVE⁩ ⁦EBMT_Cellular_Therapy⁩ on the needs for ATMP development. Which system or sensors we need, viral or non viral? One participant per hospital / company needed. surveymonkey.com/r/ATMPfaciliti…

After Movie ….. official opening of ICAT youtu.be/3kKCSJ4PuLc?fe… Cancer Center UMCU Center for Translational Immunology @ZsoltSebestyen

Excellent time in Utrecht giving seminar and talking science with Jurgen Kuball and Zsolt Sebestyen and colleagues :)

oncodeaccelerator.nl/news/joining-f…

⏺️ Live from 📍 Milan: We have just opened the joint meeting of Immunology and Cellular Therapies in Autoimmune Diseases! 💡 During the next few days, this event hosted by the Autoimmune Diseases Working Party (ADWP) and the Cellular Therapy and Immunobiology Working Party

Joined meeting in Milano CART in auto immune diseases and finally a joined picture of our amazing team 😀 ⁦Annalisa Ruggeri⁩ ⁦Jurgen Kuball⁩ ⁦Florent Malard⁩ ⁦Simona Pagliuca⁩

The 1st Joint Educational Meeting of the Autoimmune Diseases & EBMT_Cellular_Therapy Working Parties in Milan was a success! 👏 The event brought together top experts and a broad international audience to discuss advances in cellular therapies, particularly CAR-T, in relation to

Amazing session at ⁦CTGCT⁩ with ⁦Jane Kinghorn UCL and Heiko van der Leyen in Ljubljana on how to make translational medicine in ATMP development more efficient and attractive to a next generation of researchers, regulators and investors.

Do you know how to design innovative CAR T cells? The TCR is an incredible inspiration and has tons to teach us! Check our latest perspective in Nat Rev Immunology: rdcu.be/dXDkG You will find a new exciting way to look at CAR T cells! CIBSS Faculty of Biology - University of Freiburg Universität Freiburg

Excellent review from the lab about CAR design 😍 Look inside 👀

🔎 Have you seen this publication in Bone Marrow Transplantation? 📰 Severe ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL & PMBCL in Europe: a survey on behalf of the Cellular Therapy & Immunobiology Working

The GoCART_Coalition is an inclusive initiative bringing together many stakeholders interested in the development of IECs based therapies. Results of the first supported scientific projects now coming out. Congratulations

Help spread the word! 😊📢 Christian Chabannon Alex Rampotas Jordan Gauthier Esra Gülderen @YasSerroukh Satya Prakash Yadav Mohamad Mohty Ibrahim Yakoub-Agha Felipe Peña Muñoz Zina Peric Vera Radici Claire Horgan Krzysztof Kałwak Lars Klingen Gjærde @BldCancerDoc Akshay Sharma MD Rafael Duarte Jurgen Kuball

CONGRESS #ASH24 | POSTER @Jkuball, UMC Utrecht, presented a poster on MSCs in SR-aGvHD. ORR at day 7 was 26.5% and 44.5% at day 28. At 12 mo, NRM was 58.8%. 84.8% of day 7 responders maintained response to day 28. Follow our live feed for more updates: gvhdhub.com/medical-inform…

Work supported by EBMT_Cellular_Therapy Annalisa Ruggeri Florent Malard

Excellent presentation of ⁦Christian Chabannon⁩ on tisagenlecleucel for the Management of Patients with R/R DLBCL: an Interim Report of the European PASS Conducted by EBMT ⁦EBMT_Cellular_Therapy⁩ ⁦Annalisa Ruggeri⁩

It’s always about creating and using better alternatives ….. now also on ….. bsky.app/profile/jkubal… bsky.app/profile/jkubal…